T Man Pharmaceutical PCL
SET:TMAN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
T Man Pharmaceutical PCL
SET:TMAN
|
TH |
|
Avantia Co Ltd
TSE:8904
|
JP |
|
Evogene Ltd
NASDAQ:EVGN
|
IL |
|
Nicco Parks & Resorts Ltd
BSE:526721
|
IN |
|
Advan Group Co Ltd
TSE:7463
|
JP |
|
H
|
Hangzhou Heshun Technology Co Ltd
SZSE:301237
|
CN |
|
G
|
Grupo Minsa SAB de CV
BMV:MINSAB
|
MX |
|
Takada Corp
TSE:1966
|
JP |
|
Japan Post Holdings Co Ltd
TSE:6178
|
JP |
|
ACSL Ltd
TSE:6232
|
JP |
Cash Flow Statement
Cash Flow Statement
T Man Pharmaceutical PCL
| Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|
| Operating Cash Flow | |||||
| Net Income |
573
|
441
|
449
|
523
|
|
| Depreciation & Amortization |
135
|
118
|
120
|
126
|
|
| Other Non-Cash Items |
126
|
100
|
113
|
106
|
|
| Cash Interest Paid |
122
|
108
|
104
|
103
|
|
| Change in Working Capital |
(130)
|
(154)
|
(200)
|
(419)
|
|
| Cash from Operating Activities |
702
N/A
|
505
-28%
|
483
-4%
|
336
-30%
|
|
| Investing Cash Flow | |||||
| Capital Expenditures |
(206)
|
(154)
|
(177)
|
(226)
|
|
| Other Items |
(546)
|
(345)
|
(346)
|
358
|
|
| Cash from Investing Activities |
(752)
N/A
|
(500)
+34%
|
(523)
-5%
|
131
N/A
|
|
| Financing Cash Flow | |||||
| Net Issuance of Common Stock |
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
469
|
771
|
656
|
(212)
|
|
| Cash Paid for Dividends |
0
|
(80)
|
(176)
|
(176)
|
|
| Other |
(1 407)
|
(1 358)
|
(1 217)
|
(28)
|
|
| Cash from Financing Activities |
227
N/A
|
497
+119%
|
427
-14%
|
(417)
N/A
|
|
| Change in Cash | |||||
| Net Change in Cash |
177
N/A
|
502
+183%
|
387
-23%
|
51
-87%
|
|
| Free Cash Flow | |||||
| Free Cash Flow |
496
N/A
|
350
-29%
|
306
-13%
|
110
-64%
|
|